Thomas Kudsk Larsen
Investor Relations Contact at SANOFI
Profile
Thomas Kudsk Larsen is currently the Head-Investor Relations at Sanofi.
Previously, he worked as an Investor Relations Contact at AstraZeneca PLC.
From 2011 to 2014, he served as the Head-Investor Relations North America at Roche Holdings, Inc. In the future, from 2021 to 2023, he will be the Head-Communication & Investor Relations at Swedish Orphan Biovitrum AB.
Mr. Larsen completed his undergraduate degree at Copenhagen Business School.
Thomas Kudsk Larsen active positions
Companies | Position | Start |
---|---|---|
SANOFI | Investor Relations Contact | - |
Former positions of Thomas Kudsk Larsen
Companies | Position | End |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | 2023-03-31 |
ASTRAZENECA PLC | Investor Relations Contact | 2021-07-31 |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Investor Relations Contact | 2014-08-31 |
Training of Thomas Kudsk Larsen
Copenhagen Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
SANOFI | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Private companies | 1 |
---|---|
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas Kudsk Larsen